Since we also observed that plasma levels of pro-inflammatory mediators, such as MCP-1, IFN-γ, TNF-α and IL-6, were significantly decreased by apigenin, these changes could be partly associated with the decreased fat accumulation, improved insulin resistance and glucose homeostasis in apigenin-supplemented obese mice. The gene discussed is IFNG; the disease is Insulin resistance.